Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 97

    1.

    Pinpointing key mechanisms in Alzheimer's disease development.

    Williams J.

    Alzheimers Res Ther. 2010 Mar 31;2(2):4.

    PMID:
    20359316
    [PubMed]
    Free PMC Article
    2.

    Final Report on Carcinogens Background Document for Formaldehyde.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.

    PMID:
    20737003
    [PubMed - as supplied by publisher]
    3.

    Inflammation in the Alzheimer's disease cascade: culprit or innocent bystander?

    Tan ZS, Seshadri S.

    Alzheimers Res Ther. 2010 Apr 12;2(2):6.

    PMID:
    20388190
    [PubMed]
    Free PMC Article
    4.

    Final Report on Carcinogens Background Document for Styrene.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.

    PMID:
    20737009
    [PubMed - as supplied by publisher]
    5.

    The early involvement of the innate immunity in the pathogenesis of late-onset Alzheimer's disease: neuropathological, epidemiological and genetic evidence.

    Eikelenboom P, Veerhuis R, van Exel E, Hoozemans JJ, Rozemuller AJ, van Gool WA.

    Curr Alzheimer Res. 2011 Mar;8(2):142-50. Review.

    PMID:
    21345167
    [PubMed - indexed for MEDLINE]
    6.

    Position statement. Part one: Immune function and exercise.

    Walsh NP, Gleeson M, Shephard RJ, Gleeson M, Woods JA, Bishop NC, Fleshner M, Green C, Pedersen BK, Hoffman-Goetz L, Rogers CJ, Northoff H, Abbasi A, Simon P.

    Exerc Immunol Rev. 2011;17:6-63. Review.

    PMID:
    21446352
    [PubMed - indexed for MEDLINE]
    Free Article
    8.

    Advances and perspectives from genetic research: development of biological markers in Alzheimer's disease.

    Zetzsche T, Rujescu D, Hardy J, Hampel H.

    Expert Rev Mol Diagn. 2010 Jul;10(5):667-90. Review.

    PMID:
    20629514
    [PubMed - indexed for MEDLINE]
    9.

    Vascular factors and markers of inflammation in offspring with a parental history of late-onset Alzheimer disease.

    van Exel E, Eikelenboom P, Comijs H, Frölich M, Smit JH, Stek ML, Scheltens P, Eefsting JE, Westendorp RG.

    Arch Gen Psychiatry. 2009 Nov;66(11):1263-70.

    PMID:
    19884614
    [PubMed - indexed for MEDLINE]
    Free Article
    10.

    Innate Immunity and the Etiology of Late-Onset Alzheimer's Disease.

    Eikelenboom P, van Exel E, Veerhuis R, Rozemuller AJ, van Gool WA, Hoozemans JJ.

    Neurodegener Dis. 2012 Jan 17. [Epub ahead of print]

    PMID:
    22261470
    [PubMed - as supplied by publisher]
    11.

    Genetic predisposition to inflammation: a new risk factor of Alzheimer's disease.

    Wan Y, Wang G, Chen SD.

    Neurosci Bull. 2008 Oct;24(5):314-22. Review.

    PMID:
    18839025
    [PubMed - indexed for MEDLINE]
    12.

    Age-related inflammatory diseases: role of genetics and gender in the pathophysiology of Alzheimer's disease.

    Candore G, Balistreri CR, Grimaldi MP, Vasto S, Listì F, Chiappelli M, Licastro F, Lio D, Caruso C.

    Ann N Y Acad Sci. 2006 Nov;1089:472-86. Review.

    PMID:
    17261790
    [PubMed - indexed for MEDLINE]
    13.

    Phagocytosis of amyloid-beta and inflammation: two faces of innate immunity in Alzheimer's disease.

    Fiala M, Cribbs DH, Rosenthal M, Bernard G.

    J Alzheimers Dis. 2007 Jul;11(4):457-63. Review.

    PMID:
    17656824
    [PubMed - indexed for MEDLINE]
    14.

    Vascular risk and genetics of sporadic late-onset Alzheimer's disease.

    Panza F, D'Introno A, Colacicco AM, Basile AM, Capurso C, Kehoe PG, Capurso A, Solfrizzi V.

    J Neural Transm. 2004 Jan;111(1):69-89. Epub 2003 Dec 3. Review.

    PMID:
    14714217
    [PubMed - indexed for MEDLINE]
    15.

    [Attitudes towards predictive genetic testing for Alzheimer's disease].

    Illes F, Bernhardt T, Prell K, Rietz C, Rudinger G, Frölich L, Maier W, Rietschel M.

    Z Gerontol Geriatr. 2006 Jun;39(3):233-9. German.

    PMID:
    16794889
    [PubMed - indexed for MEDLINE]
    16.

    SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease.

    Cruchaga C, Kauwe JS, Mayo K, Spiegel N, Bertelsen S, Nowotny P, Shah AR, Abraham R, Hollingworth P, Harold D, Owen MM, Williams J, Lovestone S, Peskind ER, Li G, Leverenz JB, Galasko D; Alzheimer's Disease Neuroimaging Initiative, Morris JC, Fagan AM, Holtzman DM, Goate AM.

    PLoS Genet. 2010 Sep 16;6(9). pii: e1001101.

    PMID:
    20862329
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    17.

    Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms.

    Halliday G, Robinson SR, Shepherd C, Kril J.

    Clin Exp Pharmacol Physiol. 2000 Jan-Feb;27(1-2):1-8. Review.

    PMID:
    10696521
    [PubMed - indexed for MEDLINE]
    18.

    Novel 'inflammatory plaque' pathology in presenilin-1 Alzheimer's disease.

    Shepherd CE, Gregory GC, Vickers JC, Halliday GM.

    Neuropathol Appl Neurobiol. 2005 Oct;31(5):503-11.

    PMID:
    16150121
    [PubMed - indexed for MEDLINE]
    20.

    Neurones and microglia in central nervous system immune response to degenerative processes. Part 1: Alzheimer's disease and Lewy body variant of Alzheimer's disease. Quantitative study.

    Szpak GM, Lechowicz W, Lewandowska E, Bertrand E, Wierzba-Bobrowicz T, Gwiazda E, Schmidt-Sidor B, Dymecki J.

    Folia Neuropathol. 2001;39(3):181-92.

    PMID:
    11770129
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk